A loculated pleural effusion is a pocket of fluid trapped between the lung and the chest wall by fibrin strands or adhesions, preventing it from flowing freely the way a simple effusion does. While a straightforward pleural effusion pools at the lowest point and shifts with gravity, loculated fluid stays put, walled off in one or more compartments that resist standard drainage. This distinction matters because loculated collections are harder to treat, often signal a more serious underlying process, and frequently require a different management strategy than their free-flowing counterparts.
How Fluid Becomes Trapped
Pleural fluid normally slides in a thin layer between the two membranes lining your lungs and chest wall. When inflammation hits that space, the body responds with its usual repair toolkit: it releases fibrin, the same protein mesh that forms the framework of a blood clot. In the pleural space, fibrin strands stretch from one membrane to the other and begin to partition the fluid into isolated pockets. The longer inflammation continues, the more organized these partitions become. What starts as a few wispy strands can progress to thick, rubbery membranes that essentially trap fluid in sealed compartments.
Infection is the most common driver of this process. When bacteria invade the pleural space during pneumonia, the inflammatory cascade is intense and rapid. Fibrin production ramps up, white blood cells flood in, and the fluid shifts from thin and straw-colored to thick and purulent. But infection is not the only cause. Malignant effusions, tuberculosis, bleeding into the pleural space, and even long-standing heart failure can trigger loculation if enough inflammation is present.
Why It Matters for Drainage
A simple effusion can usually be drained with a single needle or small catheter placed at the lowest point of the collection. Gravity does most of the work. A loculated effusion resists this approach because the fluid is compartmentalized. A drain placed into one pocket will empty that pocket but leave the rest untouched. Clinicians sometimes discover loculation only when a drain that initially worked well suddenly stops producing fluid, even though imaging still shows a large collection. This scenario is one of the most common early clues.
Small-bore chest drains, which are generally well tolerated and effective for simple effusions, fail more often when loculation is present.1PubMed Central. The effectiveness of small-bore intercostal catheters versus large-bore chest tubes in the management of pleural disease with the systematic review of literature The septations physically block the tube from accessing all the trapped fluid. This is why recognizing loculation early changes the treatment plan: you need different tools to break down those internal walls before drainage can succeed.
Spotting Loculation on Imaging
Chest X-rays can raise suspicion for loculation when an effusion does not shift position on decubitus views (images taken with the patient lying on their side), but they are not reliable for confirming it. The two imaging tools that matter are ultrasound and CT, and they are not equally good at this job.
Ultrasound has a clear edge. A study comparing the two head-to-head found that ultrasound detected septations with a sensitivity of about 83% and a specificity of 100%, while CT managed only about 60% sensitivity and 87% specificity.2Scientific Reports. Chest ultrasound is better than CT in identifying septated effusion of patients with pleural disease In practical terms, ultrasound almost never calls a septated effusion when there isn’t one, and it catches the majority of cases that CT misses. This finding is well supported in the pleural medicine literature: thoracic ultrasound is consistently more sensitive than CT for identifying septations within pleural fluid.3European Respiratory Review. Thoracic ultrasound in the modern management of pleural disease
The reason for this discrepancy is partly about timing and partly about physics. Ultrasound visualizes the fluid in real time, and the thin fibrin strands that create septations show up beautifully against the dark background of fluid. CT, by contrast, captures a single moment and can struggle to distinguish subtle strands from volume-averaging artifacts. CT still has its role: it is better at showing the overall anatomy, identifying underlying lung disease, and distinguishing an empyema from a lung abscess based on wall characteristics and how the collection relates to surrounding structures.4PubMed. Differentiating lung abscess and empyema: radiography and computed tomography But for the specific question of whether an effusion is loculated, ultrasound is the tool to reach for first.
The Main Causes
Pleural infection is by far the most frequent reason for loculation. When pneumonia spreads to the pleural space, the resulting parapneumonic effusion can progress through stages: first a simple, free-flowing collection, then a complicated effusion with fibrin formation, and finally frank empyema with thick pus. Loculation typically appears in the complicated and empyema stages. The bacterial culprits vary. In children, Streptococcus pneumoniae dominates, identified in the vast majority of culture-positive pediatric pleural infections.5Respiratory Medicine. Etiology of parapneumonic effusion and pleural empyema in children In critically ill adults, the picture shifts: aerobic gram-negative bacteria are increasingly common, and mixed infections involving anaerobes are also seen.6PubMed. The changing pathogens of complicated parapneumonic effusions or empyemas in a medical intensive care unit
Tuberculosis is another major cause worldwide. TB-related pleural effusions loculate frequently, and there is an interesting clinical wrinkle: when a TB effusion is loculated, it is far more likely to yield a positive mycobacterial culture from the fluid. One study found that loculation was independently associated with dramatically higher odds of growing TB bacteria in culture, making it a useful predictor for clinicians trying to confirm the diagnosis.7PubMed Central. Loculated Tuberculous Pleural Effusion: Easily Identifiable and Clinically Useful Predictor of Positive Mycobacterial Culture from Pleural Fluid
Malignant effusions can also become loculated, particularly in patients with advanced cancer who have had repeated pleural procedures or prior pleurodesis attempts. The presence of septations in a malignant effusion carries a grimmer outlook: these patients tend to have a worse prognosis, and the septations make symptom control more difficult.8Europe PMC. Management of Septated Malignant Pleural Effusions
Fluid Analysis and What It Tells You
When fluid is successfully obtained from a loculated collection, its characteristics help guide management. In the setting of infection, the pH of the pleural fluid is one of the most useful markers. A very low pH points toward complicated parapneumonic effusion or empyema: studies show the lowest values in empyema, averaging around 6.8, compared to simple transudative effusions that sit near a normal 7.5.9Egyptian Journal of Chest Diseases and Tuberculosis. Diagnostic significance of pleural fluid pH and pCO2 A pH below 7.2 in an infected effusion is a widely used threshold suggesting that antibiotics alone will not be sufficient and the fluid needs to be drained. When the fluid is also visibly purulent, frankly loculated, or growing bacteria on culture, the case for aggressive intervention is strong.
Breaking Down the Walls With Fibrinolytics
Since the fundamental problem in a loculated effusion is fibrin creating barriers, the logical medical approach is to dissolve those barriers. This is the role of intrapleural fibrinolytic therapy, and the landmark advance in this area was the combination of tissue plasminogen activator (tPA) with DNase, an enzyme that breaks down DNA released from dead white blood cells. The DNA makes the infected fluid viscous and sticky; the fibrin traps it in pockets. You need both enzymes working together.
A large randomized trial demonstrated that the combination of tPA and DNase instilled through a chest drain reduced the area of pleural opacity on imaging by about 30%, compared to roughly 17% with placebo. Neither tPA alone nor DNase alone performed better than placebo, confirming that the synergy between the two drugs is essential. The combination also cut surgical referrals at three months from 16% to 4% and shortened hospital stays by nearly a week.10PubMed. Intrapleural Use of Tissue Plasminogen Activator and DNase in Pleural Infection
Real-world observational data has reinforced these findings. In one series, tPA/DNase increased the volume of fluid drained in the first 24 hours from a median of about 250 ml before treatment to roughly 2,500 ml over the 72 hours after, with a corresponding drop in the amount of visible effusion on imaging.11Annals of the American Thoracic Society. Intrapleural Tissue Plasminogen Activator and Deoxyribonuclease for Pleural Infection. An Effective and Safe Alternative to Surgery Another study looking specifically at complex effusions from abdominal causes (things like pancreatitis and subdiaphragmatic abscesses) found an overall treatment success rate of about 88%, with drainage volumes nearly tripling and patients reporting substantially improved breathlessness.12Annals of the American Thoracic Society. Safety and Efficacy of Tissue Plasminogen Activator and DNase for Complicated Pleural Effusions Secondary to Abdominal Pathology
There is a caveat for malignant effusions. While fibrinolytics do reduce the visible size of septated malignant collections on imaging, this radiographic improvement has not consistently translated into better breathlessness relief or improved pleurodesis success.13Europe PMC. Management of Septated Malignant Pleural Effusions The fibrin strands may be only part of the problem in malignancy; tumor coating the lung surface can prevent the lung from re-expanding even after the fluid is cleared.
When Surgery Is Needed
Fibrinolytics work for most patients with loculated pleural infections, but not all. When medical therapy fails, the next step is usually video-assisted thoracoscopic surgery (VATS), a minimally invasive approach that allows a surgeon to enter the pleural space with a camera and instruments, break apart the loculations by hand, wash out the infected material, and place drains under direct visualization. VATS is a well-established option for fibrinopurulent-stage empyema, though its success rate drops as the disease moves into its most advanced organized stage, where a thick peel of fibrous tissue encases the lung.14Europe PMC. Minimally invasive thoracic surgery for empyema
At that late stage, open thoracotomy with decortication may be required. This is a bigger operation: the surgeon opens the chest, peels the fibrous rind off the lung surface, and allows the lung to re-expand. Patients who reach this point typically show substantial pleural thickening on imaging.15PubMed Central. Early Thoracotomy and Decortication in Pleural Empyema The key clinical lesson is that the longer loculated infected fluid sits in the chest, the more likely it is to progress to this organized phase, which is harder and riskier to treat surgically. This is why prompt recognition and early intervention matter.
The Cost and Timing Question
A common clinical dilemma is whether to try fibrinolytics first and reserve surgery for failures, or whether to go straight to VATS. Economic modeling suggests that starting with tPA/DNase is the more cost-effective strategy. One analysis found that while surgical decortication was slightly cheaper in raw procedural costs (roughly $13,300 vs. $14,000 for fibrinolysis), the fibrinolysis-first approach yielded better health outcomes at one year, making it the more cost-effective choice overall. The analysis favored fibrinolysis as the initial therapy as long as its probability of success stayed above 60%.16PubMed Central. Cost-Effectiveness Analysis of Fibrinolysis versus Thoracoscopic Decortication for Early Empyema
This “fibrinolytics first, surgery if needed” sequence has become the dominant approach at most centers, though timing remains debated. Waiting too long to escalate to surgery if fibrinolytics are failing carries its own risks: a patient whose sepsis is worsening or whose lung is becoming increasingly trapped should not sit through repeated courses of intrapleural therapy when the clinical trajectory is clearly downhill.
Loculations in Children
Empyema in children has been rising in incidence over recent decades, and loculation is common in pediatric cases. The treatment debate mirrors the adult discussion: fibrinolytics through a chest drain versus VATS. A prospective randomized trial in children found no significant difference in hospitalization duration, time to becoming afebrile, or pain medication requirements between the two approaches. About 17% of children who started with fibrinolysis eventually needed VATS, but no child in the fibrinolysis group clinically worsened after starting therapy. VATS, meanwhile, carried higher charges and was associated with complications including the need for ventilator support in some cases.17PubMed Central. Thoracoscopic decortication vs tube thoracostomy with fibrinolysis for empyema in children: a prospective, randomized trial
A systematic review and meta-analysis pooling data from multiple pediatric trials confirmed this picture: treatment failure rates were comparable between fibrinolysis and VATS, as were serious adverse events. Fibrinolysis was associated with longer hospital stays but lower costs.18PubMed. Intrapleural Fibrinolytic Therapy Versus Video-Assisted Thoracoscopic Surgery, as the Initial Treatment Modality, in Children with Empyema Thoracis: A Systematic Review and Meta-Analysis The overall certainty of evidence was rated very low, reflecting the small size of the available trials, so the “right” answer depends partly on local expertise and family preferences.
Loculations Around Indwelling Pleural Catheters
Patients with recurrent malignant effusions sometimes have a tunneled indwelling pleural catheter (IPC) placed for long-term home drainage. Loculations can develop around these catheters over time, typically appearing about two months after insertion, and affect somewhere between 5% and 14% of IPC-treated patients.19BMJ. Complications of indwelling pleural catheter use and their management The patient notices that their catheter, which used to drain well, is producing less and less fluid despite persistent breathlessness and visible effusion on imaging.
Instilling fibrinolytics through the existing IPC can rescue drainage in the majority of these cases. A multicenter study found that fluid drainage improved in about 93% of patients and breathlessness improved in 83% after intrapleural fibrinolytic therapy via the IPC. The visible effusion on chest X-ray shrank from an average of about half the hemithorax to roughly a third. The approach carried a small risk of pleural bleeding, occurring in about 3% of patients.20PubMed. Intrapleural Fibrinolysis for the Treatment of Indwelling Pleural Catheter-Related Symptomatic Loculations: A Multicenter Observational Study This is a meaningful advantage: it avoids the need for a second invasive procedure in patients who are often frail and dealing with advanced cancer.
Saline Lavage as a Simpler Adjunct
Not every center has immediate access to tPA/DNase, and the drugs are not cheap. Intrapleural saline lavage, where sterile saline is instilled through a chest drain and then allowed to drain back out, has been studied as a simpler alternative or supplement. A cohort study found that repeated saline lavage was effective and safe for managing pleural empyema, including in patients with comorbidities like cancer, though it required longer hospitalization than more aggressive approaches.21PubMed. Saline lavage for the management of severe pleural empyema: A cohort study Saline lavage is sometimes used alongside fibrinolytics in practice, helping to flush out debris loosened by the enzymes, though formal evidence comparing combination protocols is limited.
A Condition With Ancient Roots
Pleural infection and the drainage problems it causes are among the oldest documented medical conditions. Hippocrates described draining the pleural space over 2,000 years ago. The practice of closed pleural drainage became standard during the 1917–1919 influenza pandemic, when post-pneumonic empyema was devastating patients at scale.22European Respiratory Review. Empyema thoracis: new insights into an old disease What has changed over the last century is not the fundamental problem but the tools available: ultrasound guidance has transformed the accuracy of drain placement, fibrinolytic therapy has given clinicians a way to dissolve loculations without surgery, and VATS has replaced open surgery for most patients who do need an operation. The challenge of fluid trapped behind fibrin walls, though, remains as relevant as it was in the ancient Mediterranean.